Biogen appoints ex-Sanofi chief Christopher Viehbacher as CEO

Biogen appoints ex-Sanofi chief Christopher Viehbacher as CEO

Source: 
Medical Marketing and Media
snippet: 

Biogen announced Thursday that former Sanofi CEO Christopher Viehbacher will serve as the company’s next CEO.

The biotech said Viehbacher, who spent 20 years at GSK before a six-year stint at the helm of Sanofi, will replace outgoing CEO Michel Vounatsos. The company first announced in its Q1 earnings report that it would begin a search to replace Vounatsos as CEO.